Immunological recovery after 3 years’ antiretroviral therapy in HIV-1-infected children
- 1 February 2002
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (3) , 483-486
- https://doi.org/10.1097/00002030-200202150-00022
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Viral phenotype affects the thymic production of new T cells in HIV-1-infected childrenAIDS, 2001
- Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAARTClinical and Experimental Immunology, 2001
- Differential responses of T cell subsets: possible role in the immunopathogenesis of AIDSAIDS, 2000
- Effect of HIV on Thymic Function before and after Antiretroviral Therapy in ChildrenThe Journal of Infectious Diseases, 2000
- Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected childrenThe Lancet, 1998
- Different Meaning of CD38 Molecule Expression on CD4+ and CD8+ Cells of Children Perinatally Infected with Human Immunodeficiency Virus Type 1 Infection Surviving Longer than Five YearsPediatric Research, 1998
- Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferationNature Medicine, 1998
- Elevated CD38 Antigen Expression on CD8+ T Cells Is a Stronger Marker for the Risk of Chronic HIV Disease Progression to AIDS and Death in the Multicenter AIDS Cohort Study Than CD4+ Cell Count, Soluble Immune Activation Markers, or Combinations of HLA-DR and CD38 ExpressionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997